Andrew Blumenfeld M.D

Dr Andrew Blumenfeld is Director of: The Los Angeles Headache Center with offices in San Diego and Los Angeles.

He is Board-certified in Neurology by the American Board of Psychiatry and Neurology and is also certified in Headache Medicine.
Dr Blumenfeld is a member and fellow of both the American Academy of Neurology and the American Headache Society. He is the founding chair of the American Headache Society section on Interventional Procedures for Headache. He has published widely and has over 100 publications.

One of his manuscripts was voted the top publication in the Headache journal.
His research interests have focused on the use of Botox for migraine. He helped to develop the injection protocol used in the pivotal migraine trials. He teaches other providers on this procedure nationally and internationally.

He has been an active researcher in headache with 26 issued patents for various treatments.

He consults with numerous pharmaceutical companies involved with medications related to headache disorders, and more details can be found through The Sunshine Act.

Board Certification

Medical Education

St. Andrews College, South Africa
First class pass and distinction in Mathematics,  1975

University of the Witwatersrand Faculty of Medicine, Johannesburg, South Africa
Bachelor of Medicine and Surgery (MD equivalent), 1976-1981

Johannesburg Hospital, South Africa, 1981-1982
Internship, General Surgery Resident, Internal Medicine Resident

No. 1 Military Hospital, South Africa, 1983-1984
Medical Officer (Full Lieutenant), Department of internal medicine

Johannesburg Hospital, South Africa 1985-1986
Neurology Resident, Department of Neurology

University of Massachusetts Medical School  1986-1989
Neurology Resident, Department of Neurology

University of Massachusetts Medical School 1989-1990
Neurophysiology Fellow: EEG and EMG Fellowship


California Medical License Number – A47863Published Journals

Published Journals


Advisory Board: Allergan, Abbvie, Aeon, Alder, Amgen, Axsome, BDSI, Biohaven, Impel, Lundbeck, Lilly, Novartis, Revance, Teva, Theranica, Zoscano

Speaker: Allergan, Abbvie, Amgen, Biohaven, Lundbeck, Lilly, Teva, BDSI
Consultant: Allergan, Abbvie, Alder, Amgen, Biohaven, Lilly, Lundbeck, Novartis, Teva, Theranica

Grant support: Allergan, Amgen

Contributing author: Allergan, Abbvie, Amgen, Novartis, Teva, Lilly, Biohaven